Chen Hao Lo

8PUBLICATIONS
49CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMedical biochemistry - inorganic elements and compoundsPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 03, 2023
γδ-Enriched CAR-T cell therapy for bone metastatic castrate-resistant prostate cancer.

Jeremy S Frieling, Leticia Tordesillas, Xiomar E Bustos

|Mar 30, 2023
Phagocytosis increases an oxidative metabolic and immune suppressive signature in tumor macrophages.

Michael A Gonzalez, Daniel R Lu, Maryam Yousefi

|May 13, 2022
Integrated computational and in vivo models reveal Key Insights into macrophage behavior during bone healing.

Etienne Baratchart, Chen Hao Lo, Conor C Lynch

|Feb 02, 2021
Mesenchymal stem cell-derived interleukin-28 drives the selection of apoptosis resistant bone metastatic prostate cancer.

Jeremy J McGuire, Jeremy S Frieling, Chen Hao Lo

|Feb 02, 2021
Host-Derived Matrix Metalloproteinase-13 Activity Promotes Multiple Myeloma-Induced Osteolysis and Reduces Overall Survival.

Chen Hao Lo, Gemma Shay, Jeremy J McGuire

|Jun 30, 2020
Histone deacetylase inhibition prevents the growth of primary and metastatic osteosarcoma.

Jeremy J McGuire, Niveditha Nerlakanti, Chen Hao Lo

Pageof 2

Frequent Collaborators

4 joint publications

Conor C Lynch

2 joint publications

Jeremy S Frieling

1 joint publications

Matthew H Spitzer

1 joint publications

Ning Zhao